According to a new report by Polaris Market Research, the global oncology-based molecular diagnostics market was valued at USD 3.66 billion in 2024 and is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% over the forecast period. Growth is underpinned by rising cancer incidence worldwide, expanding adoption of precision oncology testing, and accelerating...